IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $811,550 | +231110.8% | 115,277 | +100.4% | 0.01% | +100.0% |
| Q1 2023 | $351 | -42.0% | 57,527 | -39.2% | 0.01% | -58.3% |
| Q4 2022 | $605 | -99.9% | 94,629 | +20.1% | 0.01% | -25.0% |
| Q3 2022 | $755,000 | -24.4% | 78,780 | -12.9% | 0.02% | -38.5% |
| Q2 2022 | $999,000 | +97.4% | 90,494 | +198.0% | 0.03% | +116.7% |
| Q1 2022 | $506,000 | -69.7% | 30,370 | -65.3% | 0.01% | -57.1% |
| Q4 2021 | $1,671,000 | +41.3% | 87,532 | +82.4% | 0.03% | +47.4% |
| Q3 2021 | $1,183,000 | -75.1% | 47,982 | -68.0% | 0.02% | -80.0% |
| Q1 2021 | $4,752,000 | +441.8% | 150,091 | +369.9% | 0.10% | +120.9% |
| Q2 2020 | $877,000 | +496.6% | 31,938 | +68.1% | 0.04% | +975.0% |
| Q3 2017 | $147,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |